Superoxide and its interaction with nitric oxide modulates renal function in prehypertensive Ren-2 transgenic rats

被引:16
|
作者
Kopkan, Libor [1 ]
Huskova, Zuzana
Vanourkova, Zdenka
Thumova, Monika
Skaroupkova, Petra
Cervenka, Ludek
Majid, Dewan S. A.
机构
[1] Ctr Med Expt, Inst Clin & Expt Med, CZ-14000 Prague, Czech Republic
[2] Tulane Univ, Hlth Sci Ctr, Hypertens & Renal Ctr Excellence, Dept Physiol, New Orleans, LA 70118 USA
[3] Cardiovasc Res Ctr, Prague, Czech Republic
关键词
angiotensin II; hypertension; nitric oxide; renal function; superoxide;
D O I
10.1097/HJH.0b013e3282efb195
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective The present study was performed to examine the role of superoxide (O-2(-)) and its interaction with nitric oxide (NO) in the regulation of renal function in prehypertensive heterozygous Ren-2 transgenic rats (TGR). Methods Renal responses to the O-2(-) scavenger, tempol (150 mu g/min per 100 g), and/or the NO synthase inhibitor, nitro-L-arginine methylester (L-NAME; 5 mu g/min per 100 g), infused alone or in combination directly into the renal artery were evaluated in anesthetized heterozygous male TGR and aged-matched Hanover Sprague-Dawley rats (HanSD). Results There were no differences in arterial pressure (122 +/- 3 versus 115 +/- 2 mmHg), renal plasma flow (RPF; 2.09 +/- 0.1 versus 2.07 +/- 0.1 ml/min per g), glomerular filtration rate (GFR; 0.73 +/- 0.1 versus 0.74 +/- 0.1 ml/min per g) or sodium excretion (0.63 +/- 0.13 versus 0.67 +/- 0.16 mu mol/min per g) between TGR and HanSD. Tempol alone caused significant increases in RPF and GFR (10 +/- 4% and 12 +/- 2%, respectively) in TGR but not in HanSD. Tempol also caused greater sodium excretory responses in TGR compared to HanSD (1112 +/- 16% versus 43 +/- 7%; P< 0.05). 8-Isoprostane excretion was significantly higher in TGR than in HanSD (10.2 +/- 0.8 versus 6.5 +/- 0.7 pg/min per g), which was attenuated by tempol. L-NAME caused greater decreases in RPF and GFR in TGR (-34 +/- 4% and -22 +/- 4%, respectively) than in HanSD (-19 +/- 3% and -10 +/- 4%, respectively). Co-infusion of tempol partially attenuated the renal hemodynamic and excretory responses to L-NAME in TGR. Conclusions These data suggest that the enhanced O-2(-) activity and its interaction with NO during the prehypertensive phase in TGR modulates renal hemodynamic and excretory function, which may contribute to the development of hypertension in this transgenic rat model.
引用
收藏
页码:2257 / 2265
页数:9
相关论文
共 50 条
  • [21] Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic rats
    Vernerova, Zdenka
    Kramer, Herbert J.
    Baecker, Angela
    Cervenka, Ludek
    Opocensky, Martin
    Huskova, Zuzana
    Vanourkova, Zdenka
    Eis, Vaclav
    Chabova, Vera Certikova
    Tesar, Vladimir
    Maly, Jan
    Vaneckova, Ivana
    VASCULAR PHARMACOLOGY, 2008, 48 (4-6) : 165 - 173
  • [22] Exaggerated blood pressure response to fasudil or nifedipine in hypertensive Ren-2 transgenic rats: role of altered baroreflex
    Vaneckova, Ivana
    Behuliak, Michal
    Hojna, Silvie
    Kopkan, Libor
    Kadlecova, Michaela
    Zicha, Josef
    HYPERTENSION RESEARCH, 2019, 42 (02) : 145 - 154
  • [23] Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats
    Rakusan, Dan
    Kujal, Petr
    Kramer, Herbert J.
    Huskova, Zuzana
    Vanourkova, Zdenka
    Vernerova, Zdenka
    Mrazova, Iveta
    Thumova, Monika
    Cervenka, Ludek
    Vaneckova, Ivana
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2010, 299 (04) : F758 - F766
  • [24] Role of angiotensin II in chronic blood pressure control of heterozygous Ren-2 transgenic rats: Peripheral vasoconstriction versus central sympathoexcitation
    Rezacova, Lenka
    Hojna, Silvie
    Kopkan, Libor
    Rauchova, Hana
    Kadlecova, Michaela
    Zicha, Josef
    Vaneckova, Ivana
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 116
  • [25] Renal Nitric Oxide Synthase and Antioxidant Preservation in Cyp1a1-Ren-2 Transgenic Rats With Inducible Malignant Hypertension
    Cunningham, Mark W., Jr.
    Sasser, Jennifer M.
    West, Crystal A.
    Milani, Carlo J.
    Baylis, Chris
    Mitchell, Kenneth D.
    AMERICAN JOURNAL OF HYPERTENSION, 2013, 26 (10) : 1242 - 1249
  • [26] ANG-II DEPENDENCE OF TUBULOGLOMERULAR FEEDBACK RESPONSIVENESS IN HYPERTENSIVE REN-2 TRANSGENIC RATS
    MITCHELL, KD
    MULLINS, JJ
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1995, 268 (05): : F821 - F828
  • [27] Moderate additive effects of endothelin receptor A blockade in Ren-2 transgenic rats subjected to various types of RAS blockade
    Vaneckova, Ivana
    Rezacova, Lenka
    Kunes, Jaroslav
    Zicha, Josef
    LIFE SCIENCES, 2016, 159 : 127 - 134
  • [28] Enhanced superoxide activity modulates renal function in NO-deficient hypertensive rats
    Kopkan, L
    Majid, DSA
    HYPERTENSION, 2006, 47 (03) : 568 - 572
  • [29] Renal Sympathetic Denervation Attenuates Congestive Heart Failure in Angiotensin II-Dependent Hypertension: Studies with Ren-2 Transgenic Hypertensive Rats with Aortocaval Fistula
    Honetschlagerova, Zuzana
    Gawrys, Olga
    Jichova, Sarka
    Skaroupkova, Petra
    Kikerlova, Sona
    Vanourkova, Zdenka
    Huskova, Zuzana
    Melenovsky, Vojtech
    Kompanowska-Jezierska, Elzbieta
    Sadowski, Janusz
    Kolar, Frantisek
    Novotny, Jiri
    Hejnova, Lucie
    Kujal, Petr
    Cervenka, Ludek
    KIDNEY & BLOOD PRESSURE RESEARCH, 2021, 46 (01) : 95 - 113
  • [30] Both central sympathoexcitation and peripheral angiotensin II-dependent vasoconstriction contribute to hypertension development in immature heterozygous Ren-2 transgenic rats
    Rezacova, Lenka
    Vaneckova, Ivana
    Hojna, Silvie
    Vavrinova, Anna
    Valovic, Pavol
    Rauchova, Hana
    Behuliak, Michal
    Zicha, Josef
    HYPERTENSION RESEARCH, 2022, 45 (03) : 414 - 423